Search

everythinglearnresearchcommunity

for

Search:↓

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

The new method found new shared genetic areas linked to both Type 2 Diabetes and Prostate Cancer.

Exposure to low doses of finasteride in the womb causes changes in the prostate of both male and female gerbils.

DHA derivatives, especially didocosahexaenoin, effectively kill prostate cancer cells and may offer a safer cancer treatment option.

Obesity is linked to more severe lower urinary tract symptoms.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

Combining doxazosin and finasteride is more effective for managing benign prostatic hyperplasia than using either drug alone.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

The oils showed potential to kill certain cancer cells, especially from Dysphania ambrosioides.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Testosterone therapy increases bone density in older men with low testosterone levels.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Mutations in the androgen receptor gene cause androgen insensitivity, leading to female traits in genetically male individuals.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.

Finasteride effectively treats baldness but may cause sexual side effects.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.